Recapitulation of endochondral bone formation using human adult mesenchymal stem cells as a paradigm for developmental engineering by Scotti, Celeste et al.
Institutional Repository of the University of Basel 
University Library
Schoenbeinstrasse 18-20
CH-4056 Basel, Switzerland 
http://edoc.unibas.ch/
Year: 2010 
Recapitulation of endochondral bone formation using human adult 
mesenchymal stem cells as a paradigm for developmental engineering 
Scotti, Celeste and Tonnarelli, Beatrice and Papadimitropoulos, Adam and Scherberich, Arnaud and 
Schaeren, Stefan and Schauerte, Alexandra and Lopez-Rios, Javier and Zeller, Rolf and Barbero, Andrea and 
Martin, Ivan 
Posted at edoc, University of Basel 
Official URL: http://edoc.unibas.ch/dok/A6003625 
Originally published as: 
Scotti, Celeste and Tonnarelli, Beatrice and Papadimitropoulos, Adam and Scherberich, Arnaud and 
Schaeren, Stefan and Schauerte, Alexandra and Lopez-Rios, Javier and Zeller, Rolf and Barbero, Andrea and 
Martin, Ivan. (2010) Recapitulation of endochondral bone formation using human adult mesenchymal stem 
cells as a paradigm for developmental engineering. Proceedings of the National Academy of Sciences of the 
United States of America, Vol. 107, H. 16. S. 7251-7256. 
1BIOLOGICAL SCIENCES (Applied Biological Sciences) 
RECAPITULATION OF ENDOCHONDRAL BONE FORMATION 
USING HUMAN ADULT MESENCHYMAL STEM CELLS: A 
PARADIGM FOR DEVELOPMENTAL ENGINEERING 
1,2*Celeste Scotti, 1*Beatrice Tonnarelli, 1Adam Papadimitropoulos, 1Arnaud Scherberich, 
1Stefan Schaeren, 3Alexandra Schauerte, 3Javier Lopez-Rios, 3Rolf Zeller , 1#Andrea Barbero, 
1#Ivan Martin 
1Departments of Surgery and of Biomedicine, University Hospital Basel, Hebelstrasse 20, 
4056, Basel, Switzerland 
2Residency Program in Orthopaedics and Traumatology, Università degli Studi di Milano, 
Milano, Italy  
3Developmental Genetics, Department of Biomedicine, University of Basel, Mattenstrasse 28, 
4058, Basel, Switzerland 
*C.S. and B.T. contributed equally to this study
#Corresponding authors 
Address correspondence to: Ivan Martin and Andrea Barbero 
ICFS, University Hospital Basel 
Hebelstrasse 20, ZLF, Room 405 
4031 Basel, Switzerland 
Phone: + 41 61 265 2384; fax: + 41 61 265 3990 
e-mail: imartin@uhbs.ch; abarbero@uhbs.ch 
Manuscript information: 19 pages, 5 figures 
 2
ABSTRACT 
Mesenchymal Stem/Stromal Cells (MSC) are typically used to generate bone tissue by a 
process resembling intra-membranous ossification, i.e. by direct osteoblastic differentiation. 
However, most bones develop by endochondral ossification, i.e. via remodeling of 
hypertrophic cartilaginous templates. To date, endochondral bone formation has not been 
successfully reproduced using human, clinically compliant cell sources. Here, we aimed at 
engineering tissues from bone marrow-derived, adult human MSC with an intrinsic capacity 
to undergo endochondral ossification. By analogy to embryonic limb development, we 
hypothesized that successful execution of the endochondral ossification program depends on 
the initial formation of hypertrophic cartilaginous templates. Human MSC, subcutaneously 
implanted into nude mice at various stages of chondrogenic differentiation, formed 
interconnected bone trabeculae only when they had developed in vitro hypertrophic tissue 
structures. Advanced maturation in vitro resulted in accelerated formation of larger bony 
tissues. The underlying morphogenetic process was structurally and molecularly similar to the 
temporal and spatial progression of limb bone development in embryos. In particular, Indian 
Hedgehog signalling was activated at early stages and required for the in vitro formation of 
hypertrophic cartilage. Subsequent development of a bony collar in vivo was followed by 
vascularisation, osteoclastic resorption of the cartilage template and appearance of 
hematopoietic foci. This study reveals the capacity of human MSC to generate bone tissue via 
an endochondral ossification program and provides a valid model to study mechanisms 
governing bone development. Most importantly, this process could be engineered to generate 
advanced grafts for bone regeneration by invoking a “developmental engineering” paradigm. 
KEYWORDS 
endochondral ossification; hypertrophic chondrocytes; bone development; regenerative 
medicine; tissue engineering  
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INTRODUCTION 
Endochondral ossification, namely the formation of bone tissue by replacement of cartilage 
templates, is the route through which long bones and the axial skeleton are formed in 
developing embryos (1). This process relies on the highly specialized morpho-regulatory 
functions of hypertrophic chondrocytes (2). Hypertrophic chondrocytes derive from the initial 
condensation of mesenchymal precursors and begin to produce a type X collagen-rich 
avascular cartilaginous matrix. At the periphery of this cartilage tissue, the so called 
“borderline” hypertrophic chondrocytes (3) instruct surrounding mesenchymal cells to 
differentiate into osteoblasts, which results in formation of the typical “bony collar”. In 
parallel, chondrocytes in the central regions direct mineralization of the hypertrophic cartilage 
by initiating remodeling via the production of specific matrix metalloproteinases (MMP) and 
attract blood vessels by releasing vascular-endothelial growth factor (VEGF). The in-growing 
blood vessels deliver osteoblastic, osteoclastic and hematopoietic precursors, which mediate 
resorption of the deposited cartilaginous template and formation of vascularized bone tissue 
containing the so-called stromal sinusoids, which provide the microenvironment for 
hematopoiesis (1). 
Mesenchymal stem/stromal cells (MSC) from human adults have the ability to generate bone 
tissue in a variety of experimental models (4), and hold great potential for bone repair in 
regenerative medicine. Thus far, MSC have been shown to generate bone tissue exclusively 
through direct osteogenic differentiation (i.e. in a manner akin to intra-membranous 
ossification), using a mineralized surface as “priming” substrate, with the exception of 
implantation in confined environments that prevent blood vessel invasion (e.g. diffusion 
chambers; ref. 5, 6). This approach has already been used for a few clinical trials (7), but has 
not been effective for wide-spread clinical application (4). The possibility to engineer MSC-
based grafts that would recapitulate the morphogenetic processes and endochondral 
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ossification occurring during embryonic skeletal bone development would represent an 
important step forward for physiological bone repair, in line with the recently defined 
“developmental engineering” concepts (8). In particular, the proposed route to bone formation 
through cartilage remodeling and vascularisation, which is also activated during successful, 
natural bone fracture repair, would potentially allow to overcome issues critical to the 
physiological functioning of engineered bone grafts, such as osteogenic performance, 
resistance to hypoxic conditions and efficiency of engraftment. So far, evidence of ectopic 
bone tissue morphogenesis via formation of hypertrophic cartilage templates have been 
reported for murine embryonic stem cells (ESC) (9) and chick embryonic mesenchymal cells 
(10), but the paradigm has thus far not been reproduced using human ESC or clinically 
potentially more relevant sources such as adult human MSC (9). The present study aimed at 
establishing and characterizing an endochondral bone tissue engineering approach, which uses 
bone marrow-derived, human adult MSC. By analogy to embryonic development of long 
bones, we hypothesized that the stage of cartilage hypertrophy reached in vitro by MSC 
would critically impact on the process of endochondral ossification following implantation 
into the nude mouse model. Our results demonstrate that engineered human hypertrophic 
cartilaginous tissue have the potential to undergo developmental changes similar to the ones 
during limb formation. Therefore, this study paves the way towards a “developmental 
engineering” approach for the regeneration of bone.  
 
RESULTS 
In vitro maturation of engineered hypertrophic cartilage tissues 
Since endochondral bone formation is initiated by condensation and chondrogenic 
differentiation of mesenchymal cells, we cultured human adult MSC in a transwell, scaffold-
free system to maximize cell-cell interactions (11), using a serum-free medium supplemented 
with TGFβ1 as a potent inducer of chondrogenesis (12). After one week, the resulting tissues 
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had deposited a loose extracellular matrix, which was faintly positive for glycosaminoglycans 
(GAG). These specimens will be hereafter referred to as “pre-chondrogenic” tissues. After 2 
weeks, the resulting tissues displayed clear cartilaginous features, including positive Safranin-
O staining for GAG (Fig. 1a) and large cells in lacunae embedded in abundant matrix 
(positive for type II collagen; Fig. 1c). As only low and localized levels of type X collagen, 
which marks hypertrophic chondrocytes, were detected (Fig. 1e), these specimens will be 
hereafter referred to as “early hypertrophic” tissues. At this stage, type I collagen was 
detected throughout the tissue (Fig. 1g), with staining intensity increased in the outer rim. In 
this outer rim, low levels of bone sialoprotein (BSP) were also detected (Fig. 1i), but no sign 
of matrix mineralization was apparent (Fig. 1k).  
In order to induce a more mature hypertrophic phenotype in human MSC, cells were cultured 
for 3 weeks in chondrogenic medium as described above and then for a further 2 weeks in 
medium lacking TGFβ1, but supplemented with β-glycerophosphate and l-thyroxin (13, 14). 
This culture protocol maintained the chondrogenic features, namely GAG and type II collagen 
expression (Fig. 1b, 1d), but also promoted abundant and widespread accumulation of type X 
collagen (Fig. 1f). The outer rim of the specimens was uniformly positive for type I collagen 
(Fig. 1h) and developed a distinct mineralized collar (Fig. 1l), strongly positive for BSP (Fig. 
1j). This histological pattern is characteristic of what was previously defined as “chondro-
osseous rudiment” (15), and therefore specimens at this stage will be hereafter referred to as 
“late hypertrophic” tissues. The progression of chondrogenesis through hypertrophy and 
mineralization between 2 and 5 weeks of in vitro culture was paralleled by increased 
expression of type X collagen (CX; 4.2-fold), MMP13 (3.7-fold), core-binding factor alpha 
subunit 1 (Cbfa1; 7.2-fold), osteocalcin (OC; 430-fold), and bone sialoprotein (BSP; 5.7-fold) 
transcripts (Fig. 1m, 1n). Following hypertrophic differentiation, phenotypic analysis by cell 
flow cytometry demonstrated an overall decrease in the expression of markers typical for 
undifferentiated MSC (CD73, CD90, CD105, CD146) and an increase of alkaline phosphatase 
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(ALP; Fig. S1). Vascular endothelial growth factor (VEGF) transcript, released protein and 
matrix-bound protein were detected at similar levels throughout the culture stages (Fig. S2). 
 
Progression of bone development following in vivo implantation of hypertrophic 
cartilage constructs 
Both pre-chondrogenic, early hypertrophic and late hypertrophic constructs were implanted 
subcutaneously into nude mice and harvested after 4 and 8 weeks. Pre-chondrogenic 
constructs could not be recovered following implantation, as they were likely resorbed by the 
host environment. Following 4 weeks in vivo, early hypertrophic samples developed into 
structures containing cells embedded in large lacunae within an extracellular matrix rich in 
GAG (Fig. 2a) and type X collagen (Fig. 2e), while BSP deposition was confined in the outer 
rim (Fig. 2i). Eight weeks after implantation, the extracellular matrix extensively remodeled, 
displayed reduced GAG levels (Fig. 2b) and diffuse deposition of BSP (including the central 
regions, Fig. 2j). In the central region BSP overlapped with type X collagen (compare Fig. 2j 
to Fig. 2f). Four weeks after implantation, late hypertrophic samples displayed two distinct 
regions: an outer osteoid tissue, which resembled a bony collar, and an inner cartilaginous 
region, which was faintly positive for GAG (Fig. 2c). Type X collagen was present 
predominantly in the peri-cellular space (Fig. 2g), partially overlapping the accumulation of 
BSP (Fig. 2k). After 8 weeks in vivo, the cartilaginous template was almost completely 
resorbed, and bone ossicles appeared also in the central region (Fig. 2d, 2h, 2l).  
Taken together, these results indicate that (i) a hypertrophic cartilaginous template is required 
to prime the endochondral ossification process, and (ii) the maturation of early hypertrophic 
samples toward the endochondral route progresses upon in vivo implantation, albeit it being 
delayed in comparison to implantation of late hypertrophic tissues. 
 
In vivo remodeling and vascularisation of late hypertrophic cartilage 
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To assess if the progression of tissue morphogenesis in vivo closely resembled normal 
endochondral ossification, late hypertrophic specimens were analyzed in more detail. Four 
weeks after implantation, the outer regions corresponding to the bony collar were positive for 
MMP-13 (Fig. 3a), which is typically expressed by late hypertrophic chondrocytes or 
osteoblasts and acts upstream of initiating angiogenesis (16). Indeed, capillary vessels positive 
for CD31 (PECAM-1) began to penetrate the outer matrix (Fig. 3b, 3c), consistent with the 
requirement to transport host osteoclasts, nutrients and pro-apoptotic signals to the internal 
hypertrophic cartilaginous template (1, 17). After 8 weeks in vivo, cartilaginous regions 
undergoing remodeling were surrounded by multi-nucleated cells of the osteoclastic lineage, 
as revealed by their positive staining for two markers typically expressed at this stage of 
resorption (18), namely tartrate-resistant acid phosphatase (TRAP; Fig. 3d) and MMP-9 (Fig. 
3e). The ongoing, active matrix digestion process was confirmed by abundant expression of 
the so-called cryptic epitope of aggrecan (DIPEN; Fig. 3f), which is exposed specifically upon 
MMP-mediated cleavage of aggrecan (19).  
 
 Activation of signalling pathways involved in normal endochondral ossification 
We next performed a real-time RT-PCR and in situ hybridization (ISH) analysis of the 
expression of key components of signalling pathways, which are known to be required for 
normal endochondral ossification during embryonic development (20, 21, 22). In particular, 
the expression of Indian Hedgehog (IHH) as upstream signal, its receptor Patched1 (PTCH1) 
and GLI1 as mediator of IHH signal transduction was assessed. As expected, all these genes 
were either not expressed or expressed at very low levels in post-expanded MSC, while their 
expression levels were markedly increased in the early hypertrophic and even more in the late 
hypertrophic constructs (IHH: 5.2 fold, PTCH1: 3.0 fold, GLI1: 7.8-fold - when comparing 
late to early hypertrophic tissues; Fig. 4a). In contrast, the expression of the other two 
Hedgehog ligands present in vertebrate species including humans (Sonic Hedgehog: SHH and 
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Desert hedgehog: DHH) was not activated (Fig. 4a). Similar to IHH, BMPs (BMP-2: 36.5 
fold, BMP-4: 7.8 fold, BMP-7: 169.4 fold), Parathyroid hormone-related protein (PTHLH: 
30.8 fold) and its receptor (PTHR1: 6.2 fold) were significantly up-regulated in late as 
compared to early hyperthrophic tissues (Fig. 4a). This shows that the progression towards 
endochondral ossification, both in vitro and in vivo, is paralleled by the activation and/or up-
regulation of the key signalling pathways involved in endochondral bone formation during 
embryonic limb skeletal morphogenesis (Fig. 4a-4d, Fig. S3). The human specificity of the 
ISH probes further allows to conclude that implanted cartilaginous templates included not 
only cells which provided signals initiating endochondral ossification (i.e., IHH), but also 
cells which responded to such signals (i.e., by expressing  GLI1), and thus activated the 
required morphogenetic pathways (i.e., by expression of BMP-7). The functional importance 
of IHH signal transduction was further evidenced by the fact that its selective inhibition by 
cyclopamine administration (23) to in vitro cultured cartilaginous templates derived from 
human MSC completely blocked their morphogenesis and maturation (Fig. 4e, f, g).  
 
Characterization and quantification of the engineered endochondral bone tissue 
Quantitative microtomography (μCT) of explants confirmed that deposition of mineralized 
matrix in early hypertrophic samples was negligible at 4 weeks after implantation and 
remained confined to the outer rim at 8 weeks (Fig. 5a, b). In contrast, late hypertrophic 
constructs contained abundant peripheral mineral deposits already at 4 weeks and displayed 
an interconnected network of trabeculae throughout the core at 8 weeks after implantation 
(Fig. 5c, d). Not only the quantity (Fig. 5e), but also the stage of maturation of the mineralized 
matrix was more advanced in late hypertrophic tissues, as revealed by the significantly higher 
mineral density (Fig. 5f) at both time points and by the lamellar morphology of the osteoid 
(Fig. 5g, h). The complete loss of type X collagen in the lamellar structures of late 
hypertrophic tissues after 8 weeks in vivo contrasted with the remaining expression and partial 
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overlap with osteocalcin in the early hypertrophic constructs (Fig. 5i, j). This result indicates 
that shortened maturation in vitro may delay progression of endochondral ossification in vivo. 
To further investigate whether prolonged maturation in vivo would be able to compensate for 
shorter periods of in vitro culture, early hypertrophic constructs were analyzed 11 weeks after 
implantation, which results in a total period of in vitro and in vivo development equal to late 
hypertrophic samples analyzed 8 weeks after implantation. Interestingly, early hypertrophic 
samples analyzed after 11 weeks displayed features of mature bone formation, although they 
remained significantly smaller than late hypertrophic constructs after 8 weeks of implantation 
(Fig. S4). It is currently debated whether the bone formed by endochondral ossification is 
exclusively generated by osteoblastic progenitors delivered by the vasculature or also by cells 
within the hypertrophic cartilaginous template (15). We thus assessed our explants by ISH for 
the presence of human Alu repeat sequences. The presence of positive cells within the 
trabeculae of the bone and the surrounding soft tissue demonstrates an active contribution of 
the human MSC in the newly formed bone tissue and thus an effective intrinsic osteogenic 
property of the engineered grafts (Fig. 5k, l). Due to the non-clonality of the original human 
MSC population, our results are however not conclusive with respect to the controversial 
issue whether bone cells derive by direct phenotypic conversion of hypertrophic chondrocytes 
or by direct osteoblastic differentiation of different MSC subsets (15). Endochondral 
skeletogenesis is known to generate a marrow microenvironment, which is prerequisite for 
hematopoiesis (24). Morphological analysis provided evidence for hematopoietic foci in some 
areas neighboring the bone matrix generated by the human adult MSC (Fig. S5a), which 
further validates the endochondral ossification process. Support for possibly ongoing 
hematopoiesis in these foci was provided by the presence of CD146+ stromal cells (25), 
which were detected in the tissue constructs (Fig. S5b).  
 
DISCUSSION 
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In this study, we report a hitherto not described capacity of adult expanded human MSC to 
generate de novo bone tissue in vivo through endochondral ossification. The observed 
endochondral morphogenesis bears striking features of normal endochondral ossification as is 
typical for limb skeletal development, namely (i) cellular condensation and hypertrophic 
chondrogenesis, (ii) functional dependence on IHH signalling, (iii) formation of a bony collar 
by perichondral ossification, (iv) MMP-mediated matrix remodeling, vascularisation, and 
osteoclastic activity, (v) bone matrix deposition over the resorbed cartilaginous template, and 
(vi) formation of complete bone tissue, which likely includes functional hematopoietic foci.  
 Our study shows that activation of the endochondral ossification program requires a 
mature hypertrophic cartilaginous template obtained in vitro (late hypertrophic constructs) or 
in vivo (early hypertrophic constructs), in which cells expressing high levels of type X 
collagen are surrounded by osteoblastic cells expressing high levels of BSP. These 
observations are consistent with the fact that the development of long bones is triggered by 
the formation of a vis-à-vis pattern between hypertrophic chondrocytes at the lateral aspects 
of the rudiment and differentiating osteoblasts in the surrounding mesenchymal tissues (26). 
Interestingly, the progression of bone formation in vivo was regulated by the developmental 
stage and size of the hypertrophic cartilaginous constructs generated in vitro for implantation. 
The need for a fine coordination between the stage of hypertrophy reached in vitro and the 
time required to achieve endochondral ossification in vivo is further confirmed by the reported 
absence of ‘frank’ trabecular bone tissue in a previous study where chondrogenically 
differentiated human MSC were implanted ectopically (27). 
The ectopic, “inert” subcutaneous implantation model used for this study allowed us to 
demonstrate that the hypertrophic cartilaginous constructs contained all necessary “biological 
instructions” to initiate a developmental process with similarities to what is observed during 
limb skeletal bone development (i.e. activation and up-regulation of IHH, BMP and PTHLH 
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signalling, and self-organization of the tissue in a spatially and temporally coordinated 
manner). The experimental concept described here is in line with the ideas of “developmental 
engineering”, in that an engineered construct is able to progress through development and 
differentiation into a structured tissue in a manner comparable to normal progression of 
embryonic development (28). In particular, no instructive external signals seem required after 
implantation and MSC were able to form bone tissue without a ceramic/mineral substrate, 
which is typically necessary to ‘prime’ differentiation into functional osteoblasts (6, 29). This 
may open the possibility either to use the tissue itself as a scaffold (this study) or - in case a 
predefined size and shape is required - to introduce different types of materials (e.g. synthetic 
polymers) with can be easier processed or tailored with respect to their physical and/or 
mechanical properties and could be better biodegradable than ceramic scaffolds (30).  
By mimicking normal developmental processes during bone engineering and repair, the 
endochondral route of MSC differentiation into bone we describe here could provide 
significant biological and practical advantages in comparison to engineering approaches 
relying on intra-membranous ossification. For example, implantation of a hypertrophic 
cartilage template in contrast to a construct delivering undifferentiated MSC or osteoblasts, 
may be better suited to overcome the initial lack of vascularisation and associated hypoxia. In 
fact, hypertrophic chondrocytes can accelerate graft invasion by blood vessels (e.g. by release 
of angiogenic factors and production of MMPs) and are physiologically functional even at 
reduced oxygen tension (31). Moreover, considering the different composition and 
metabolism of bone tissues formed by intra-membranous and endochondral morphogenesis 
(32), and the concept that bone repair processes should avoid major differences with normal 
developmental programs (33), MSC-driven bone formation via endochondral ossification 
could lead to more successful engraftment. Our study warrants further investigations towards 
a clinical implementation of the developed paradigm, including (i) scaling-up of the 
constructs implanted and (ii) orthotopic implantation in an immunocompetent animal model 
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as biomechanical and inflammatory/immune mechanisms likely participate in regulating the 
bone forming potential of the hypertrophic templates. Finally, it will be interesting to assess 
the contribution of host cells in the observed processes, possibly in immunocompetent models 
(34), and if hypertrophic cartilage constructs without cells might be able to initiate 
endochondral ossification by recruiting host progenitors. Experiments in this direction would 
open the attractive possibility to manufacture biological off-the-shelf grafts relying on the 
properties of a cell-laid extracellular matrix. 
In conclusion, we describe the first model based on human adult MSC, which 
recapitulates certain aspects of normal endochondral bone formation during embryonic 
development. The model system described is of clinical relevance for bone engineering and/or 
regeneration. Furthermore, it can be used to study the cellular/molecular mechanisms that 
control endochondral bone formation by human adult MSC isolated from both normal 
individuals and patients affected by specific diseases.   
 
MATERIALS AND METHODS 
All human samples were collected with informed consent of the involved individuals and all 
mouse experiments were performed in accordance with Swiss law. All studies were approved 
by the responsible veterinary and ethics authorities. Human mesenchymal stem cells (MSC) 
were expanded for 2 passages and cultured in transwell (5x105 cells/insert) for 1 week or 2 
weeks in a chondrogenic medium (with TGFβ1; “pre-chondrogenic” and “early 
hypertrophic” respectively), or for 3 weeks in chondrogenic medium followed by 2 weeks in a 
hypertrophic medium (without TGFβ1 and with beta-glycerophosphate and thyroxine; “late 
hypertrophic”). During in vitro culture, selected transwells were supplemented with KAAD-
cyclopamine and cultured for 5 weeks. The resulting tissues were analysed histologically, 
immunohistochemically, biochemically (glycosaminoglycans and DNA) and by real time RT-
PCR. Both pre-chondrogenic, early hypertrophic and late hypertrophic tissues were 
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implanted subcutaneously in nude mice and retrieved after 4 or 8 weeks. Tissue development 
in vivo was evaluated histologically, immunohistochemically and by µCT. The survival and 
contribution to bone formation by MSC was evaluated with in situ hybridization for human 
Alu sequences. Non-radioactive RNA in situ hybridization analysis on paraffin sections (in 
vitro and in vivo constructs) was also performed using human antisense riboprobes specific 
for IHH, GLI1 and BMP7. A more complete and detailed description of the methods is 
included in the online supplemental information. 
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Figure Legends 
Figure 1. In vitro maturation of hypertrophic cartilage tissues engineered from human 
adult MSC 
In vitro culture conditions determined the composition and structure of the tissues generated. 
(a, c, e, g) Early hypertrophic samples displayed a cartilaginous ECM rich in GAG and Col II 
with deposition of Col X and Col I in defined regions. (i, k) In the periphery of early 
hypertrophic samples, low BSP levels were detected but no calcium was deposited. (b, d, f, l, 
h, j) Late hypertrophic samples underwent further maturation in vitro and developed two 
distinct regions: an inner hypertrophic core (b, d, f) rich in GAG, Col II, Col X and an outer 
mineralized rim (b, l, h, j) with a high mineral content, Col I, and BSP. All pictures were 
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taken at the same magnification, scale bar = 200μm. The insets display low magnification 
overviews of the entire tissues. (m, n) Quantitative real-time RT-PCR demonstrated an up-
regulation of hypertrophic (Col X and MMP-13) and osteogenic (cbfa-1, osteocalcin, BSP) 
markers when comparing late with early hypertrophic tissues. Post-expanded MSC remained 
in an undifferentiated state, but expressed both SOX-9 and Cbfa-1 in combination with high 
type I collagen, and low type II collagen levels. Note that all fold changes in transcript levels 
are shown in logarithmic scale. 
 
Figure 2. Development of the hypertrophic cartilage tissues following in vivo 
implantation 
The differentiation of cartilaginous constructs in vivo progressed according to their stage of in 
vitro maturation. (a, e, i) Four weeks after implantation, early hypertrophic samples had 
differentiated further towards hypertrophy, displaying larger lacunae, Col X accumulation and 
initiated BSP deposition in the outer rim. (b, f, j) Eight weeks after implantation, early 
hypertrophic samples had differentiated even further. This was evidenced by a decrease in 
GAG accumulation, while Col X was maintained and BSP had also been deposited within the 
cartilaginous core. (c, g, k) After 4 weeks, late hypertrophic specimens had undergone more 
intense remodeling, such that GAG and Col X levels were reduced, while BSP had already 
been deposited within the cartilaginous core. (d, h, l) After 8 weeks, the cartilaginous template 
was almost completely resorbed: bone structures substituted the GAG positive areas in the 
central region, while Col X and BSP positive areas were restricted to scattered islands. All the 
pictures were taken at the same magnification, scale bar = 200μm. 
 
Figure 3. In vivo remodeling and vascularisation of late hypertrophic cartilage implants 
(a) The observed remodeling resembles the temporal and spatial changes indicative of 
ongoing endochondral ossification. Hypertrophic chondrocytes located in the bony collar 
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(BC) synthesized MMP13, which is known to prepare the ECM for vascular invasion during 
endochondral ossification. (b, c) Newly formed vessels, identified by CD31+ endothelial 
cells, penetrated the outer matrix and reached the inner core in close proximity to the 
cartilaginous areas undergoing remodeling (arrows). (d, e) The cartilaginous regions were 
colonized by TRAP-positive cells synthesizing MMP9. (f) These regions were also positive 
for the cryptic epitope of aggrecan (DIPEN), which is produced by MMP-mediated cleavage 
of aggrecan. Scale bars = 100μm. 
 
Figure 4. Activation of signalling pathways involved in endochondral bone formation in 
embryos 
Signalling pathways typically involved in endochondral ossification were activated in the 
engineered samples. (a) Real-time RT-PCR analysis indicated that MSC cultured under 
hypertrophic conditions up-regulated the expression of genes in the IHH signalling pathway 
(involving IHH, GLI1 and PTCH1), BMPs and parathyroid hormone-related protein 
signalling (PTHLH, PTHR1). Note that all fold changes in transcript levels are shown in 
logarithmic scale. (b, c, d) Four weeks after implantation, the expression of representative 
genes was assessed by in situ hybridization (IHH, GLI1, and BMP7). (e-g) Functional 
inhibition of the IHH pathway by cyclopamine treatment significantly reduced the expression 
of genes involved in IHH signalling (IHH, GLI1, PTCH1), PTH signalling (PTHLH, 
PTHR1), as well as chondrogenic/hypertrophic genes (Col II, VEGF), and osteogenic genes 
(Cbfa-1, Col I, BSP). Cyclopamine also blocked the differentiation and maturation of the 
cartilaginous templates in vitro, as assessed by Safranin-O stain. Scale bars = 200μm (b, c, d) 
and  400 μm (e, f). 
Figure 5. Morphometric analysis of the engineered bone tissue 
(a-d) Three-dimensional μCT reconstructions and (e, f) quantitative histomorphometric data 
(n=4) of mineral volume and density indicate higher bone quantity and more advanced 
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maturation of late hypertrophic samples (* indicates significant differences; p<0.01). (g, h) 
Trabecular-like structures were found both in the outer bony collar and in the inner core of 
late, but not early hypertrophic samples (scale bar = 200μm). (i, j) Fluorescence 
characterization for Col X (red) and osteocalcin (green) demonstrated the presence of mature 
lamellar bone only in late hypertrophic samples (scale bar = 50μm). (k, l) In situ hybridization 
to detect human Alu repeat sequences and hematoxylin/eosin staining of serial sections 
indicate that cells derived from the human adult MSC participated in the endochondral 
ossification process and remained embedded within the bone matrix (scale bar = 100μm).  
 





